
|Podcasts|November 19, 2021
What lies ahead for vaccines
Author(s)Miranda Hester
Contemporary Pediatrics sat down with editor-in-chief Dr. Tina Q. Tan to discuss the authorization of the Pfizer/BioNTech vaccine for use in many children as well as what lies ahead in the vaccine pipeline for the pediatric population.
Advertisement
The news about the Pfizer/BioNTech COVID-19 vaccine becoming available for children aged 5 to 11 years was met with happiness by pediatricians and many parents alike. Vaccines in the pipeline could bring similar happiness if found safe and effective.
Contemporary Pediatrics sat down with editor-in-chief Dr. Tina Q. Tan to discuss the authorization of the Pfizer/BioNTech vaccine for use in many children as well as what lies ahead in the vaccine pipeline for the pediatric population.
Advertisement
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
AAP expands RSV immunization recommendations for high-risk children
2
Top 5 pediatric health headlines you missed in August 2026
3
FDA approves zilganersen (Zanvastro) as first treatment for Alexander disease
4
AAP recommends 2026-2027 COVID-19 vaccine for all infants 6 to 23 months and at-risk older children
5





